C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

BACKGROUND: High levels of C-reactive protein (CRP), an acute phase protein, proofed being associated with decreased clinical outcome in small-scale studies in diffuse large B-cell lymphoma (DLBCL). The aim of this study was to evaluate the prognostic impact of pretreatment CRP levels on overall sur...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Troppan, K T, Schlick, K, Deutsch, A, Melchardt, T, Egle, A, Stojakovic, T, Beham-Schmid, C, Weiss, L, Neureiter, D, Wenzl, K, Greil, R, Neumeister, P, Pichler, M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2014
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4090740/
https://ncbi.nlm.nih.gov/pubmed/24874478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.277
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia